Periodontal Therapeutics Market Size, Share, Status and Industry Forecast 2027

Comments · 216 Views

Periodontal Therapeutics market is estimated to attain a valuation of US$ 1.1 billion by the end of 2027

The Periodontal Therapeutics Market focuses on the development, production, and distribution of pharmaceuticals, biologics, and medical devices designed to prevent, treat, and manage periodontal diseases, including gingivitis and periodontitis. Periodontal therapeutics encompass a range of products and interventions aimed at controlling bacterial infections, reducing inflammation, promoting tissue regeneration, and restoring periodontal health. These therapies are integral components of comprehensive periodontal care protocols administered by dental professionals, periodontists, and oral health practitioners to improve oral hygiene, prevent tooth loss, and preserve overall dental wellness.

Periodontal Therapeutics market is estimated to attain a valuation of US$ 1.1 billion by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.8% during the forecast period, 2019-2027

Get a Sample Copy of the Periodontal Therapeutics Market Research Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=24614

The significant players operating in the global Periodontal Therapeutics market are- Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd

Market Drivers:

  1. Prevalence of Periodontal Diseases: The increasing prevalence of periodontal diseases, driven by factors such as poor oral hygiene, tobacco use, genetic predispositions, and systemic health conditions (e.g., diabetes, cardiovascular disease), underscores the need for effective periodontal therapeutics to address gingival inflammation, periodontal tissue destruction, and alveolar bone loss. Periodontal diseases affect millions of individuals worldwide, leading to tooth mobility, dental abscesses, and eventual tooth loss if left untreated, necessitating early intervention and ongoing periodontal maintenance.
  2. Shift Towards Minimally Invasive Treatments: The trend towards minimally invasive dentistry and conservative periodontal treatments promotes the adoption of non-surgical periodontal therapies, such as scaling and root planing (SRP), local antimicrobial agents, and adjunctive periodontal medications, as first-line interventions for managing periodontal diseases. Minimally invasive approaches preserve periodontal tissues, minimize patient discomfort, and promote faster healing, supporting patient acceptance, treatment compliance, and long-term periodontal health outcomes.
  3. Advancements in Treatment Modalities: Technological advancements, research breakthroughs, and innovations in periodontal therapeutics have led to the development of novel treatment modalities, including antimicrobial agents, host modulation therapies, growth factors, and tissue engineering scaffolds, designed to target specific pathogenic mechanisms underlying periodontal diseases. These advanced therapies offer targeted, site-specific interventions, personalized treatment options, and improved clinical outcomes for patients with refractory or aggressive forms of periodontitis.
  4. Emphasis on Preventive Oral Care: The emphasis on preventive oral care, patient education, and early intervention strategies in dentistry underscores the importance of periodontal maintenance therapies, oral hygiene instructions, and professional prophylaxis services in preventing periodontal diseases and preserving periodontal health. Dental professionals advocate for regular dental check-ups, periodontal screenings, and patient-centered care plans tailored to individual risk factors, oral health behaviors, and treatment needs to mitigate periodontal disease progression and prevent complications.

Recent Developments:

  1. Antibiotic Stewardship in Periodontics: Recent developments in antibiotic stewardship practices in periodontics emphasize judicious use, appropriate selection, and adjunctive application of antibiotics in conjunction with mechanical debridement and periodontal therapies to optimize treatment outcomes, minimize antimicrobial resistance, and reduce adverse effects associated with systemic antibiotic use. Evidence-based guidelines, microbiological testing, and targeted antibiotic therapies promote responsible antibiotic prescribing practices and personalized treatment approaches in periodontal care.
  2. Biologic Therapies and Regenerative Techniques: Biologic therapies and regenerative techniques, such as platelet-rich plasma (PRP), platelet-rich fibrin (PRF), growth factors, and guided tissue regeneration (GTR) membranes, offer promising solutions for periodontal regeneration, alveolar bone augmentation, and soft tissue repair in advanced periodontal defects. These biologically active materials stimulate tissue healing, angiogenesis, and collagen deposition, enhancing periodontal wound healing and supporting long-term periodontal stability in complex cases requiring periodontal surgery or implant placement.
  3. Microbiome Modulation and Host Response Modulation: Emerging research on the oral microbiome and host-microbe interactions in periodontal diseases drives the development of microbiome-modulating therapies, probiotics, prebiotics, and host response modulators aimed at restoring microbial balance, suppressing pathogenic bacteria, and promoting symbiotic host-microbiome relationships in periodontal tissues. Targeted antimicrobial agents, quorum sensing inhibitors, and immunomodulatory drugs offer innovative strategies for manipulating microbial communities, enhancing immune surveillance, and preventing periodontal disease recurrence.
  4. Digital Dentistry and Teleperiodontology: Digital dentistry technologies, including intraoral scanners, cone beam computed tomography (CBCT), and computer-aided design/computer-aided manufacturing (CAD/CAM) systems, enable precise treatment planning, virtual surgical simulations, and guided periodontal interventions, enhancing treatment accuracy, patient outcomes, and clinician productivity in periodontal practice. Teleperiodontology platforms, teledentistry consultations, and remote monitoring tools facilitate access to periodontal care, enable patient engagement, and improve care coordination between periodontists and general dentists, particularly in underserved or remote communities.

Market Segmentation –

ProductSystemic Antibiotics

 

  • Doxycycline
  • Minocycline
  • Metronidazole
  • Others

Local Antibiotics

  • Arestin
  • Periochip
  • Atridox
  • Others
Distribution ChannelHospital Pharmacies

 

Retail Pharmacies

Drug Stores

E-Commerce

This Report lets you identify the opportunities in Periodontal Therapeutics Market by means of a region:

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
  • South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

 

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Comments